Last reviewed · How we verify

NCT04484766: PAVA

Preeclampsia Associated Vascular Aging

Status unknown Last updated 14 April 2023
What this trial tests

trial testing Primary data collection in Pre-Eclampsia in 120 participants. Status unknown.

Timeline
1 September 2019
Primary endpoint
10 December 2021
30 June 2023

Quick facts

Lead sponsorJena University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date1 September 2019
Primary completion10 December 2021
Estimated completion30 June 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Jena University Hospital

Who can join

18 and older, female only, with Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate cardiovascular health, especially endothelial health, of women after pre-eclampsia compared to women without pre-eclampsia, and to compare women who had taken PETN during pregnancy with women who had not attempted treatment

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cardiovascular health of women 10 to 20 years after placenta-related pregnancy diseases considering the possible effect of pentaerythrityl tetranitrate treatment during pregnancy on long-term maternal cardiovascular health (PAVA study).
    Lößner C, Multhaup A, Bäz L, Lehmann T, et al · · 2024 · PMID 39405308 · DOI 10.1371/journal.pone.0309177

Verify or expand the search:

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

Other Jena University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04484766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing